Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial

Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed site revision version was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:33.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T02:42:19.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision 3.5.0 was added to the history. Revision 3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-19T05:24:50.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added and revision v3.4.2 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T01:09:17.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.4.2) indicating an update to the study record; a government funding notice and the prior revision note (v3.4.1) were removed.
    Difference
    0.9%
    Check dated 2026-02-11T11:22:03.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the page revision updated to v3.4.1, replacing the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T06:50:27.000Z thumbnail image

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.